Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

IPA ImmunoPrecise Antibodies

4.490
+0.500+12.53%
Trading Session 10/03 13:00 ET
High
4.501
Open
4.200
Turnover
77.27K
Low
4.200
Pre Close
3.990
Volume
17.80K
Market Cap
111.52M
P/E(TTM)
Loss
52wk High
6.880
Shares
24.84M
P/E(Static)
Loss
52wk Low
3.510
Float Cap
93.43M
Bid/Ask %
50.00%
Historical High
33.340
Shs Float
20.81M
Volume Ratio
1.47
Historical Low
3.510
Dividend TTM
--
Div Yield TTM
--
P/B
2.22
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.09%
Amplitude
7.55%
Avg Price
4.341
Lot Size
1
Float Cap
93.43M
Bid/Ask %
50.00%
Historical High
33.340
Shs Float
20.81M
Volume Ratio
1.47
Historical Low
3.510
Dividend TTM
--
P/B
2.22
Dividend LFY
--
Turnover Ratio
0.09%
Amplitude
7.55%
Avg Price
4.341
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.
CEO: Ms. Jennifer Bath
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...